Jardiance: new “flozin” now available for type 2 diabetesThird SGLT2 inhibitor in Canada reduces cardiovascular risk in Canadian-led clinical trial. Mid-day nap can reduce heart risks and need for BP meds, study finds Clinical Pearls: Checking patients' BP devices New practice tool to monitor patients taking direct oral anticoagulants for stroke prevention in atrial fibrillation Includes monitoring checklist and quick-reference tables for managing patients. Antidepressant use with NSAIDs may increase risk of intracranial bleed Combination therapy riskier in males, similar risk with all antidepressant classes Canadian stroke best practice recommendations: 2015 update Stronger focus on managing poststroke depression, vascular cognitive impairment and fatigue. Clinical Feature: Getting to the heart of it How pharmacists can improve adherence in patients with cardiovascular disease. New research finds pharmacist prescribing significantly reduces hypertension Evidence from RxACTION study shows it is time to move from research to implementation, says Ross Tsuyuki. Trial trumpets LDL lowering Does sitagliptin increase cardiovascular risk in diabetes patients? New study shows no apparent increased risk of major adverse cardiovascular events or hospitalization for heart failure. First Previous 39 40 41 42 43 Next Last
